These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32523890)

  • 1. High Expression of Interleukin-12A and Its Association with the Clinicopathology and Prognosis of Differentiated Thyroid Cancer.
    Zhang GQ; Shen CT; Song HJ; Qiu ZL; Luo QY
    Eur Thyroid J; 2020 May; 9(3):139-147. PubMed ID: 32523890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Characteristics-Assisted Risk Stratification for Extent of Thyroidectomy in Patients With 1-4 cm Solitary Intrathyroidal Differentiated Thyroid Cancer.
    Dong F; Zhou L; Wang S; Mao J; Liu C; Shi W
    Front Endocrinol (Lausanne); 2021; 12():790730. PubMed ID: 35211090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TUMOR SIZE IS AN INDEPENDENT PREDICTOR OF MORTALITY RISK IN DIFFERENTIATED THYROID CANCER PATIENTS WITH T4 DISEASE.
    Wang Z; Zhang Q; Ye H; Jia C; Lv Z; Liu J; Yin Z
    Endocr Pract; 2020 May; 26(5):499-507. PubMed ID: 31968190
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluating the influence of prophylactic central neck dissection on TNM staging and the recurrence risk stratification of cN0 differentiated thyroid carcinoma.
    Lin X; Chen X; Jiru Y; Du J; Zhao G; Wu Z
    Bull Cancer; 2016 Jun; 103(6):535-40. PubMed ID: 27236850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extrathyroidal Extension is an Important Predictor of Regional Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancer.
    Jain NK; Mostoufi-Moab S; Hawkes CP; Nelson ND; Surrey LF; Jones ZS; Adzick NS; Kazahaya K; Bauer AJ
    Thyroid; 2020 Jul; 30(7):1037-1043. PubMed ID: 31573414
    [No Abstract]   [Full Text] [Related]  

  • 6. The Association of Histologically Proven Chronic Lymphocytic Thyroiditis with Clinicopathological Features, Lymph Node Metastasis, and Recurrence Rates of Differentiated Thyroid Cancer.
    Aydoğan Bİ; Mutlu ABB; Yüksel S; Güllü S; Emral R; Demir Ö; Şahin M; Gedik VT; Çorapçıoğlu D; Sak SD; Erdoğan MF
    Endocr Pathol; 2021 Jun; 32(2):280-287. PubMed ID: 33188468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk for Thyroid Cancer Recurrence Is Higher in Men Than in Women Independent of Disease Stage at Presentation.
    Zahedi A; Bondaz L; Rajaraman M; Leslie WD; Jefford C; Young JE; Pathak KA; Bureau Y; Rachinsky I; Badreddine M; De Brabandere S; Fong H; Maniakas A; Van Uum S
    Thyroid; 2020 Jun; 30(6):871-877. PubMed ID: 31524071
    [No Abstract]   [Full Text] [Related]  

  • 8. Investigation of VEGF and IL-8 Gene Polymorphisms in Patients with Differentiated Thyroid Cancer.
    Kilic I; Guldiken S; Sipahi T; Palabiyik O; Akker M; Celik O; Soysal-Atile N; Tuncbilek N; Guven HM; Gundogdu AS; Sut N
    Clin Lab; 2016 Dec; 62(12):2319-2325. PubMed ID: 28164553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of differentiated thyroid cancer in relation to serum thyrotropin and thyroglobulin antibody status at time of diagnosis.
    McLeod DS; Cooper DS; Ladenson PW; Ain KB; Brierley JD; Fein HG; Haugen BR; Jonklaas J; Magner J; Ross DS; Skarulis MC; Steward DL; Maxon HR; Sherman SI;
    Thyroid; 2014 Jan; 24(1):35-42. PubMed ID: 23731273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
    Wu MH; Shen WT; Gosnell J; Duh QY
    Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Death from thyroid cancer of follicular cell origin.
    Wu HS; Young MT; Ituarte PH; D'Avanzo A; Duh QY; Greenspan FS; Loh KC; Clark OH
    J Am Coll Surg; 2000 Dec; 191(6):600-6. PubMed ID: 11129807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DOES T STAGE AFFECT PROGNOSIS IN PATIENTS WITH STAGE IV B DIFFERENTIATED THYROID CANCER?
    Li M; Trivedi N; Dai C; Mao R; Wang Y; Ning Y; Gu SZ; Huo L; Siddiqui AD
    Endocr Pract; 2019 Sep; 25(9):877-886. PubMed ID: 31170365
    [No Abstract]   [Full Text] [Related]  

  • 13. Synergic effects of histology subtype, lymph node metastasis, and distant metastasis on prognosis in differentiated thyroid carcinoma using the SEER database.
    Zhou L; Li Q; Chen S; Huang Y; Wei W; Zhang C; Wang M; Zhou W; Zeng W; Liu Z; Guo L
    Gland Surg; 2020 Aug; 9(4):907-918. PubMed ID: 32953600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative analysis of distant metastasis in differentiated thyroid cancer.
    Chen D; Huang L; Chen S; Huang Y; Hu D; Zeng W; Wang M; Zhou W; Feng H; Wei W; Zhang C; Liu Z; Guo L
    Oncol Lett; 2020 Mar; 19(3):1985-1992. PubMed ID: 32194693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergic effects of histology subtype, tumor size, and lymph node metastasis on distant metastasis in differentiated thyroid cancer.
    Liu Z; Chen S; Huang Y; Hu D; Zeng W; Wang M; Zhou W; Chen D; Feng H; Wei W; Zhang C; Zhou L; Guo L
    Ann Transl Med; 2019 Oct; 7(20):533. PubMed ID: 31807515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic outcomes in patients with 1-cm to 4-cm differentiated thyroid carcinoma according to extent of thyroidectomy.
    Choi JB; Lee SG; Kim MJ; Kim TH; Ban EJ; Lee CR; Lee J; Kang SW; Jeong JJ; Nam KH; Chung WY; Park CS
    Head Neck; 2019 Jan; 41(1):56-63. PubMed ID: 30536465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PROGNOSIS OF DIFFERENTIATED THYROID CARCINOMA IN PATIENTS WITH GRAVES DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS.
    Mekraksakit P; Rattanawong P; Karnchanasorn R; Kanitsoraphan C; Leelaviwat N; Poonsombudlert K; Kewcharoen J; Dejhansathit S; Samoa R
    Endocr Pract; 2019 Dec; 25(12):1323-1337. PubMed ID: 31412224
    [No Abstract]   [Full Text] [Related]  

  • 18. Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature.
    Qu N; Zhang L; Lu ZW; Ji QH; Yang SW; Wei WJ; Zhang Y
    Tumour Biol; 2016 Jun; 37(6):7797-808. PubMed ID: 26695148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LONG-TERM OUTCOMES AND PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA AND BONE METASTASES.
    Slook O; Levy S; Slutzky-Shraga I; Tsvetov G; Robenshtok E; Shimon I; Benbassat C; Hirsch D
    Endocr Pract; 2019 May; 25(5):427-437. PubMed ID: 30657361
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of Tumor Size and Minimal Extrathyroidal Extension in Patients with Differentiated Thyroid Cancer.
    Tam S; Amit M; Boonsripitayanon M; Busaidy NL; Cabanillas ME; Waguespack SG; Gross ND; Grubbs EG; Williams MD; Lai SY; Sturgis EM; Zafereo ME
    Thyroid; 2018 Aug; 28(8):982-990. PubMed ID: 29936892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.